Understanding ALK Gene Rearrangements In NSCLC

in mrmed •  last year 

The complicated illness known as non-small cell lung cancer (NSCLC) is fueled by a number of genetic mutations that promote tumour development. Anaplastic lymphoma kinase (ALK) gene rearrangements have been identified as a critical driver mutation in a fraction of NSCLC patients among these changes. ALK is a gene that codes for a receptor tyrosine kinase; when this gene is rearranged, ALK signalling pathways may become constitutively active.

mrmed mrmedpharmacy alkinhibitor nsclc lungcancer alectinibhydrochloride
last year by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!